CHOICE HOTELS INTERNATIONAL INC current report, 29 September 2026

Choice Hotels International, Inc. — Form 8-K Summary

Filing date: October 1, 2026. Event date: September 29, 2026. This filing reports an executive transition; it does not cover a financial reporting period.

Business context and financial information

Choice Hotels International, Inc. (NYSE: CHH) disclosed an agreed transition for its Chief Human Resources Officer, Patrick Cimerola. The filing contains no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial results.

Executive transition and compensation

  • Mr. Cimerola will transition from the CHRO role at the end of 2026.
  • Beginning January 1, 2027, he is expected to remain employed as a special advisor through June 30, 2027, supporting leadership continuity, an orderly transition, and certain strategic initiatives.
  • As special advisor, he will receive a base salary of $25,000 per month and continue participating in company benefit plans and executive perquisite programs.
  • He will not be eligible for future equity grants or a 2027 cash bonus. Previously granted, unvested equity awards will continue to vest under their existing written terms.
  • After the anticipated June 30, 2027 separation, he will be entitled to benefits associated with termination without cause under applicable company plans and his amended agreement. The applicable base salary rate is the rate in effect on December 31, 2026; the filing does not state the resulting severance amount.

Changes, outlook, and risks

The filing describes a planned personnel transition and related compensation arrangements. It provides no company-wide guidance or outlook and identifies no specific contingencies or unusual items beyond these arrangements.

Important facts to verify

  • Whether the transition from CHRO occurs at the end of 2026 as planned.
  • Whether the special-advisor arrangement and expected June 30, 2027 separation proceed on the stated schedule.
  • The value of termination-without-cause benefits, which is not quantified in this filing.
  • The treatment and vesting schedule of Mr. Cimerola’s outstanding equity awards under their governing terms.